1 |
Levy JH,Szlam F,Wolberg AS,et al.Clinical use of the activated partial thromboplastin time and prothrombin time for screening:a review of the literature and current guidelines for testing [J].Clin Lab Med,2014,34(3):453-477.
|
2 |
Wiegele M,Schöchl H,Haushofer A,et al.Diagnostic and therapeutic approach in adult patients with traumatic brain injury receiving oral anticoagulant therapy:an Austrian interdisciplinary consensus statement [J].Crit Care,2019,23(1):62.
|
3 |
Bugaev N,Como JJ,Golani G,et al.Thromboelastography and rotational thromboelastometry in bleeding patients with coagulopathy:Practice management guideline from the Eastern Association for the Surgery of Trauma [J].J Trauma Acute Care Surg,2020,89(6):999-1017.
|
4 |
Rossaint R,Afshari A,Bouillon B,et al.The European guideline on management of major bleeding and coagulopathy following trauma:sixth edition [J].Crit Care,2023,27(1):80.
|
5 |
Unruh M,Reyes J,Helmer SD,et al.An evaluation of blood product utilization rates with massive transfusion protocol:before and after thromboelastography (TEG) use in trauma [J].Am J Surg,2019,218(6):1175-1180.
|
6 |
David JS,James A,Orion M,et al.Thromboelastometry-guided haemostatic resuscitation in severely injured patients:a propensity score-matched study [J].Crit Care,2023,27(1):141.
|
7 |
Saner FH,Scarlatescu E,Broering DC,et al.The Yin and the Yang of hemostasis in end-stage liver disease [J].J Clin Med,2023,12(17):5759.
|
8 |
Janko N,Majeed A,Kemp W,et al.Viscoelastic tests as point-of-care tests in the assessment and management of bleeding and thrombosis in liver disease [J].Semin Thromb Hemost,2020,46(6):704-715.
|
9 |
Hartmann J,Dias JD,Pivalizza EG,et al.Thromboelastographyguided therapy enhances patient blood management in cirrhotic patients:a meta-analysis based on randomized controlled trials.Semin Thromb Hemost,2023,49(2):162-172.
|
10 |
Nanchal R,Subramanian R,Karvellas CJ,et al.Guidelines for the management of adult acute and acute-on-chronic liver failure in the ICU:cardiovascular,endocrine,hematologic,pulmonary,and renal considerations [J].Crit Care Med,2020,48(3):e173-e191.
|
11 |
Roberts LN,Lisman T,Stanworth S,et al.Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis:guidance from the SSC of the ISTH [J].J Thromb Haemost,2022,20(01):39-47.
|
12 |
European Association for the Study of the Liver.EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis [J].J Hepatol,2022,76(5):1151-1184.
|
13 |
Zhou J,Xin Y,Ding Q,et al.Thromboelastography predicts risks of obstetric complication occurrence in (hypo)dysfibrinogenemia patients under non-pregnant state [J].Clin Exp Pharmacol Physiol,2016,43(2):149-156.
|
14 |
Bell SF,de Lloyd L,Preston N,et al.Managing the coagulopathy of postpartum hemorrhage:an evolving role for viscoelastic hemostatic assays [J].J Thromb Haemost,2023,21(8):2064-2077.
|
15 |
Samuels JM,Moore EE,Silliman CC,et al.Severe traumatic brain injury is associated with a unique coagulopathy phenotype [J].J Trauma Acute Care Surg,2019,86(4):686-693.
|
16 |
Cannon JW,Dias JD,Kumar MA,et al.Use of thromboelastography in the evaluation and management of patients with traumatic brain injury:a systematic review and metaanalysis [J].Crit Care Explor,2021,3(9):e0526.
|
17 |
Tjerkstra MA,Wolfs AE,Verbaan D,et al.A systematic review of viscoelastic testing in patients with subarachnoid hemorrhage [J].World Neurosurg,2023,175:102-112.e5.
|
18 |
Gergi M,Goodwin A,Freeman K,et al.Viscoelastic hemostasis assays(VHA) in septic,critically ill COVID-19 patients:a practical guide for clinicians [J].Blood Coagul Fibrinolysis,2021,32(3):225-228.
|
19 |
Andersen MG,Hvas CL,Tønnesen E,et al.Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock [J].Acta Anaesthesiol Scand,2014,58(5):525-533.
|
20 |
Roh DJ,Chang TR,Kumar A,et al.Hemoglobin concentration impacts viscoelastic hemostatic assays in ICU admitted patients [J].Crit Care Med,2023,51(2):267-278.
|
21 |
Ferrucci L,Corsi A,Lauretani F,et al.The origins of age-related proinflammatory state,Blood,2005,105 (6):2294-2299.
|
22 |
Roeloffzen WW,Kluin-Nelemans HC,Mulder AB,et al.In normal controls,both age and gender affect coagulability as measured by thrombelastography [J].Anesth Analg,2010,110(4):987-994.
|
23 |
Haas T,Faraoni D.Viscoelastic testing in pediatric patients [J].Transfusion,2020,60(Suppl 6):S75-S85.
|
24 |
Carll T.Viscoelastic testing methods [J].Adv Clin Chem,2023,117:1-52.
|
25 |
Farrell MS,Moore EE,Thomas AV,et al.“Death Diamond” tracing on thromboelastography as a marker of poor survival after trauma [J].Am Surg,2021,88(07):1689-1693.
|
26 |
MacDonald SG,Luddington RJ.Critical factors contributing to the thromboelastography trace [J].Semin Thromb Hemost,2010,36(7):712-722.
|